Opdivo Use Expanded to Treat Lung Cancer
Drug Alerts , News / October 5, 2016

The FDA today expanded the approved use of Opdivo (nivolumab) to treat patients with advanced metastatic squamous non-small cell lung cancer (NSCLC) with progression on or after platinum-based chemotherapy. Opdivo works by inhibiting the cellular ...

Skip to toolbar